Trial Profile
Human Abuse Liability study of Mallinckrodt's Oxycodone/paracetamol combination in recreational opioid abusers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Mar 2015
Price :
$35
*
At a glance
- Drugs Oxycodone/paracetamol (Primary)
- Indications Pain
- Focus Pharmacodynamics
- 12 Sep 2013 Results were presented at PAINWeek 2013, and in a Mallinckrodt media release.
- 12 Sep 2013 New trial record
- 04 Sep 2013 Primary endpoint 'Psychological-measures' has been met.